Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Market Analysis and Insights: Global Nanomedicine Market
The global Nanomedicine market size is projected to reach US$ 160.3 million by 2026, from US$ 150 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Nanomedicine Scope and Market Size
Nanomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
oncology
Infectious diseases
Cardiology
Orthopedics
Others
North America
Europe
China
Japan
Southeast Asia
India
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.
Market Analysis and Insights: Global Nanomedicine Market
The global Nanomedicine market size is projected to reach US$ 160.3 million by 2026, from US$ 150 million in 2020, at a CAGR of 6.4%% during 2021-2026.
Global Nanomedicine Scope and Market Size
Nanomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Market segment by Type, the product can be split into
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Market segment by Application, split into
oncology
Infectious diseases
Cardiology
Orthopedics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.